Sublingual immunotherapy: Dosing in relation to clinical and immunological efficacy

Allergy and Asthma Proceedings

Volumn 29, Issue 2, 2008, Pages 130-139

  Larenas Linnemann, Désirée E ^a,b  

^a Research Liver Unit   (Mexico)

^b LIVER RESEARCH UNIT   (Mexico)

Author keywords

Allergen; Allergen extract; Bronchial provocation; Desensitization; Dosing; Immunoglobulin e; Immunoglobulin g4; Immunotherapy; Rhinitis; Sublingual

Indexed keywords

ALLERGEN; IMMUNOGLOBULIN E;

BLOOD; DESENSITIZATION; HUMAN; HYPERSENSITIVITY; IMMUNOLOGY; REVIEW; SUBLINGUAL DRUG ADMINISTRATION;

ADMINISTRATION, SUBLINGUAL; ALLERGENS; DESENSITIZATION, IMMUNOLOGIC; HUMANS; HYPERSENSITIVITY; IMMUNOGLOBULIN E;

EID: 43149101503     PISSN: 10885412     EISSN: None     Source Type: Journal    
DOI: 10.2500/aap.2008.29.3093     Document Type: Review

References (71)

1. Grier TJ, Hazelhurst DM, Duncan EA, et al. Major allergen measurements: sources of variability, validation, quality assurance, and utility for laboratories, manufacturers, and clinics. Allergy Asthma Proc 23:125-131, 2002.
2. Li JT, Lockey RF, Bernstein IL, et al. Allergen immunotherapy: A practice parameter. American Academy of Allergy, Asthma and Immunology. American College of Allergy, Asthma and Immunology. Ann Allergy Asthma Immunol 90:1-40, 2003.
3. US Food and Drug Administration. Available online at www.fda.gov/cber/ allergenics/allpubs.htm; last accessed Feb. 15, 2008.
4. Nordic Council on Medicines. Registration of Allergenic Preparations: Nordic Guidelines, 2nd ed. Upssala, Sweden: NLN Publications, Publication 23, 1-34. 1989.
5. Dreborg S, and Einarsson R. The major allergen content of allergenic preparations reflects their biological activity. Allergy 47:418, 1992.
6. Pajno GB. Sublingual immunotherapy: The optimism and the issues. J Allergy Clin Immunol 119:796-801, 2007.
7. Larenas-Linnemann D, Cox L, and the Immunotherapy and Allergy Diagnostics Committee of the American Academy of Allergy, Asthma and Immunology. European allergen extract units and potency: Review of available Information. Ann Allergy Asthma Immunol 100:137-145, 2008.
8. Moingeon P. Sublingual immunotherapy: From biological extracts to recombinant allergens. Allergy 61:15-19, 2006.
9. Bousquet J, Lockey RF, and Mailing HJ (Eds.). Allergen immunotherapy: Therapeutic vaccines for allergic diseases. WHO Position Paper, Geneva: January 27-29 1997. Allergy 53:1-42, 1998.
10. van Ree R. Indoor allergens: Relevance of major allergen measurements and standardization. J Allergy Clin Immunol 119: 270-277, 2007.
11. Nelson H. Immunotherapy for allergens. Where are we now? J Allergy Clin Immunol 119:769-777, 2007.
12. Cox LS, Linnemann DL, Nolte H, et al. Sublingual immunotherapy: A comprehensive review. J Allergy Clin Immunol 117:1021-1035, 2006.
13. Marogna M, Spadolini I, Massolo A, et al. Effects of sublingual immunotherapy for multiple or single allergens in polysensitized patients. Ann Allergy Asthma Immunol 98:274-280, 2007.
14. Pham-Thi N, Scheinmann P, Fadel R, et al. Assessment of sublingual immunotherapy efficacy in children with house dust mite-induced allergic asthma optimally controlled by pharmacologie treatment and mite-avoidance measures. Pediatr Allergy Immunol 18:47-57, 2007.
15. Worm M. Efficacy and tolerability of high dose sublingual immunotherapy in patients with rhinoconjunctivitis. Allerg Immunol (Paris) 38:355-360, 2006.
16. Dahl R, Kapp A, Colombo G, et al. Efficacy and safety of sublingual immunotherapy with grass allergen tablets for seasonal allergic rhinoconjunctivitis. J Allergy Clin Immunol 118:434-440, 2006.
17. Dahl R, Stender A, and Rak S. Specific immunotherapy with SQ standardized grass allergen tablets in asthmatics with rhinoconjunctivitis. Allergy 61:185-190, 2006.
18. Gomez Vera J, Flores Sandoval G, Orea Solano M, et al. Safety and efficacy of specific sublingual immunotherapy in patients with asthma and allergy to Dermatophagoides pteronyssinus. Rev Alerg Mex. 52:231-236, 2005.
19. Lue KH, Lin YH, Sun HL, et al. Clinical and immunologic effects of sublingual immunotherapy in asthmatic children sensitized to mites: A double-blind, randomized, placebo-controlled study. Pediatr Allergy Immunol 17:408-415, 2006.
20. Valovirta E, Jacobsen L, Ljorring C, et al. Clinical efficacy and safety of sublingual immunotherapy with tree pollen extract in children. Allergy 61:1177-1183, 2006.
21. Niu CK, Chen WY, Huang JL, et al. Efficacy of sublingual immunotherapy with high-dose mite extracts in asthma: A multi-center, double-blind, randomized, and placebo-controlled study in Taiwan. Respir Med 100:1374-1383, 2006.
22. Durham SR, Yang WH, Pedersen MR, et al. Sublingual immunotherapy with once-daily grass allergen tablets: A randomized controlled trial in seasonal allergic rhinoconjunctivitis. J Allergy Clin Immunol 117:802-809, 2006.
23. Didier A, Melac M, Combebias A, and André C. Efficacy and safety of sublingual immunotherapy (SLIT) tablets in grass pollen rhinoconjunctivitis. J Allergy Clin Immunol 117:721, 2006.
24. Lombardi C, Gani F, Landi M, et al. Quantitative assessment of the adherence to sublingual immunotherapy. J Allergy Clin Immunol 113:1219-1220, 2004.
25. Passalacqua G, Albano M, Riccio A, et al. Clinical and immunologie effects of a rush sublingual immunotherapy to Parietaria species: A double-blind, placebo-controlled trial. J Allergy Clin Immunol 104:964-968, 1999.
26. Tari MG, Mancino M, and Monti G. Efficacy of sublingual immunotherapy in patients with rhinitis and asthma due to house dust mite. A double blind study. Allergol Immunopathol 18:277-284, 1990.
27. Bousquet J, Van Cauwenberge P, and Khaltaev N. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 108:5147-8334, 2001.
28. Cox L, Li JT, Nelson H, and Lockey R. Allergen immunotherapy: A practice parameter second update. J Allergy Clin Immunol 120:825-585, 2007.
29. Tonnel AB, Scherpereel A, Douay B, et al. Allergic rhinitis due to house dust mites: Evaluation of the efficacy of specific sublingual immunotherapy. Allergy 59:491-497, 2004.
30. La Rosa M, Ranno C, Andre C, et al. Double-blind placebocontrolled evaluation of sublingual-swallow immunotherapy with standardized Parietaria judaica extract n children with allergic rhinoconjunctivitis. J Allergy Clin Immunol 104:425-432, 1999.
31. Cirla AM, Cirla PE, Parmiani S, and Pecora S. A pre-seasonal birch/hazel sublingual immunotherapy can improve the outcome of grass pollen injective treatment in bisensitized individuals. A case-referent, two-year controlled study. Allergol Immunopathol (Madr) 31:31-43, 2003.
32. Arikan C, Bahceciler NN, Deniz G, et al. Bacillus Calmetter-Guerin- induced interleukin-12 did not additionally improve clinical and immunolgic parameters in asthmatic children treated with sublingual immunotherapy. Clin Exp Allergy 34:398-416, 2004.
33. Bordignon V, and Burastero SE. Multiple daily administrations of low-dose sublingual immunotherapy in allergic rhinoconjunctivitis. Ann Allergy Asthma Immunol 97:158-163, 2006.
34. Álvarez-Cuesta E, Berges-Gimeno P, Mancebo EG, et al. Sublingual immunotherapy with a standardized cat dander extract: Evaluation of efficacy in a double blind placebo controlled study. Allergy 62:810-817, 2007.
35. Ciprandi G, Fenoglio D, Cirillo I, et al. Sublingual immunotherapy: An update on immunologie and functional effects. Allergy Asthma Proc 28:40-43, 2007.
36. Frati F, Moingeon P, Marcucci F, et al. Mucosal immunization application to allergic disease: Sublingual immunotherapy. Allergy Asthma Proc 28:35-39, 2007.
37. Moingeon P, Batard T, Fadel R, et al. Immune mechanisms of allergen-specific sublingual immunotherapy. Allergy 61:151-165, 2006.
38. Akdis M, and Akdis CA. Mechanisms of allergen-specific immunotherapy. J Allergy Clin Immunol 119:780-789, 2007.
39. Roder E, Berger MY, Hop WC, et al. Sublingual immunotherapy with grass pollen is not effective in symptomatic youngsters in primary care. J Allergy Clin Immunol 119:892-898, 2007.
40. 2LEN. Allergic Rhinitis and its Impact on Asthma update: Allergen immunotherapy. J Allergy Clin Immunol 119:881-891, 2007.
41. Calderon MA, Birk AO, Andersen JS, and Durham SR. Prolonged preseasonal treatment phase with Grazax sublingual immunotherapy increases clinical efficacy. Allergy 62:958-961, 2007.
42. Radulovic S, Calderon M, Wilson S, and Durham S. Sublingual immunotherapy for allergic rhinitis: An updated Cochrane systematic review and meta-analysis. Allergy 62:70-166, 2007 (Poster Discussion Sessions).
43. Mailing HJ, Lund L, Ipsen H, and Poulsen L. Safety and immunological changes during sublingual immunotherapy with standardized quality grass allergen tablets. J Investig Allergol Clin Immunol 16:162-168, 2006.
44. Till SJ, and Durham SR. Immunological responses to allergen immunotherapy. Clin Allergy Immunol 18:85-104, 2004.
45. Kildsgaard J, Brimnes J, Jacobi H, and Lund K. Sublingual immunotherapy in sensitized mice. Ann Allergy Asthma Immunol 98:366-372, 2007.
46. Wilcock LK, Francis JN, Paraskavopoulos G, et al. Induction of IL-10 occurs early and precedes serum IgG blocking activity during a cluster regimen of grass pollen immunotherapy. J Allergy Clin Immunol 117:3330, 2006.
47. Bohle B, Kinaciyan T, Gerstmayr M, et al. Sublingual immunotherapy induces IL-10-producing T regulatory cells, allergen-specific T-cell tolerance, and immune deviation. J Allergy Clin Immunol 120:707-713, 2007.
48. Bellanti JA, and Settipane RA. Sublingual immunotherapy: A procedure whose time has come? Allergy Asthma Proc 28:1-2, 2007.
49. Bahceciler NN, Isik U, Barlan IB, and Basaran MM. Efficacy of sublingual immunotherapy in children with asthma and rhinitis: A double-blind, placebo-controlled study. Pediatr Pulm 32:49-55, 2001.
50. Hirsch T, Sahn M, and Loupold W. Double-blind placebocontrolled study of sublingual immunotherapy with house dust mite extract (D. pt.) in children. Pediatr Allergy Immunol 8:21-27, 1997.
51. Mungan D, Misirligil Z, and Gurbuz L. Comparison of the efficacy of subcutaneous and sublingual immunotherapy in mite-sensitive patients with rhinitis and asthma-A placebo controlled study. Ann Allergy Asthma Immunol 82:485-490, 1999.
52. Bahceciler NN, Arikan C, Taylor A, et al. Impact of sublingual immunotherapy on specific antibody levels in asthmatic chil-dren allergic to house dust mites. Int Arch Allergy Immunol 136:287-294, 2005.
53. Pajno GB, Paassalacqua G, Vita D, et al. Sublingual immunotherapy abrogates seasonal bronchial hyperresponsiveness in children with Parietaria-induced respiratory allergy: A randomized controlled trial. Allergy 59:883-887, 2004.
54. Lombard! C, Gargioni S, Venturi S, et al. Controlled study of preseasonal immunotherapy with grass pollen extract in tablets: Effect on bronchial hyperreactivity. J Investig Allergol Clin Immunol 11:41-45, 2001.
55. Silvestri M, Spallarossa D, Battistini E, et al. Changes in inflammatory and clinical parameters and in bronchial hyperreactivity in asthmatic children sensitized to house dust mites following sublingual immunotherapy. J Investig Allergol Clin Immunol 12:52-59, 2002.
56. Marogna M, Spadolinii I, Massolo A, et al. Clinical, functional and immunologie effects of sublingual immunotherapy I birch pollinosis: A 3-year randomized controlled study. J Allergy Clin Immunol 115:1184-1188, 2005.
57. Horak F, Stubner, Berger UE, et al. Immunotherapy with sublingual birch pollen extract. A short-term double blind placebo study. Invest Allergol Clin Immunol 8:165-171, 1998.
58. Ariano R, Spadolini I, and Panzani RC. Efficacy of sublingual specific immunotherapy in Cupressaceae allergy using an extract of Cupressus arizonica. A double blind study. Allergol et Immunopathol 29:238-244, 2001.
59. Voltolini S, Modena P, Minale P, et al. Sublingual immunotherapy in tree pollen allergy. Double blind, placebo-controlled study with a biologically standardized extract of three pollens (alder, birch and hazel) administered by a rush schedule. Allergol et Immunopathol 29:103-110, 2001.
60. Marcucci F, Sensi L, Frati F, et al. Effects on inflammation parameters of a double-blind, placebo controlled one-year course of SLIT in children monosensitized to mites. Allergy 58:657-662, 2003.
61. Rolinck-Werninghaus C, Wolf H, Liebke C, et al. A prospective, randomized, double-blind, placebo-controlled multicentre study on the efficacy and safety of sublingual immunotherapy (SLIT) in children with seasonal allergic rhinoconjunctivitis to grass pollen. Allergy 59:1285-1294, 2004.
62. Troise C, Voltolini S, Canessa A, et al. Sublingual immunotherapy in Parietaria pollen-induced rhinitis: A double-blind study. J Investig Allergol Clin Immunol 5:25-30, 1995.
63. Sanchez Palacios A, Schamann F, and Garcia JA. Sublingual immunotherapy with cat epithelial extract. Personal experience. Allergol Immunopathol (Madr) 29:60-65, 2001.
64. Valle C, Bazzi S, Berra D, et al. Effects of sublingual immunotherapy in patients sensitized to Ambrosia. An open controlled study. Allergol et Immunopathol 28:311-317, 2000.
65. Bernardis P, Agnoletto M, Puccinelli P, et al. Injective versus sublingual immunotherapy in Alternaria tenuis allergic patients. J Invest Allergol Clin Immunol 6:55-62, 1996.
66. Gozalo F, Martin S, Rico P, et al. Clinical efficacy and tolerance of two year Lolium perenne sublingual immunotherapy. Allergol et Immunopathol 25:219-227, 1997.
67. Lima M, Wilson D, Pitkin L, et al. Grass pollen sublingual immunotherapy for seasonal rhinoconjunctivitis: A randomized controlled trial. Clin Exp Allergy 32:507-514, 2002.
68. Smith H, White P, Annila I, et al. Randomized controlled trial of high-dose sublingual immunotherapy to treat seasonal allergic rhinitis. J Allergy Clin Immunol 114:831-837, 2004.
69. Mortemousque B, Bertel F, De Casamayor J, et al. House-dust mite sublingual-swallow immunotherapy in perennial conjunctivitis: A double-blind, placebo-controlled study. Clin Exp Allergy 33:464-469, 2003.
70. Passalacqua G, Albano M, Fregonese L, et al. Randomized controlled trial of local allergoid immunotherapy on allergic inflammation in mite-induced rhinoconjunctivitis. Lancet 351:629-632, 1998.
71. Cistero Bahima A, Sastre J, Enrique E, et al. Tolerance and effects on skin reactivity to latex of sublingual rush immunotherapy with a latex extract. J Investig Allergol Clin Immunol 14:17-25, 2004.